跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FULVESTRANT INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FULVESTRANT INJECTION
Authorized
STANDARD
FULVESTRANT INJECTION
Mylan Pharmaceuticals ULC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6ae1049fbd081106
Company
Mylan Pharmaceuticals ULC
Type
Standard
Approval Details
Approval Id
6ae1049fbd081106
Drug Approval Canada Name
FULVESTRANT INJECTION
Product Name
FULVESTRANT INJECTION
Status
Cancelled Post Market
Status Date
2025-03-31
Original Market Date
2020-04-27
Din
02468549
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L02BA03 FULVESTRANT
Atc Name
l 02 ba 03
Aig Number
0149744001
Company Name
Mylan Pharmaceuticals ULC
Company Address
85 Advance Road, Etobicoke, Ontario, Canada, M8Z 2S6
Active Ingredients
FULVESTRANT
50 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6ae1049fbd081106
Type
Standard
Back to Health Canada Approvals